Publication:
Enucleation for ocular tumors

Simple item page
dc.contributor.authorNatta Sakolsatayadornen_US
dc.contributor.authorJulian D. Perryen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherCleveland Clinic Foundationen_US
dc.date.accessioned2018-11-09T02:46:51Z
dc.date.available2018-11-09T02:46:51Z
dc.date.issued2014-01-01en_US
dc.description.abstract© Springer-Verlag Berlin Heidelberg 2014. Many studies over the past decade report a trend toward fewer enucleations, suggesting that improved treatments prevent end-stage eye disease. Interestingly, however, the incidence of enucleation for neoplasia has not decreased despite the more widespread use of globe-sparing techniques, such as chemotherapy and brachytherapy.en_US
dc.identifier.citationClinical Ophthalmic Oncology: Orbital Tumors, Second Edition. (2014), 165-173en_US
dc.identifier.doi10.1007/978-3-642-40492-4_15en_US
dc.identifier.other2-s2.0-84956846893en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/34462
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84956846893&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleEnucleation for ocular tumorsen_US
dc.typeChapteren_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84956846893&origin=inwarden_US

Files

Collections

Scopus 2011-2015